1296. Deputy Ken O'Flynn asked the Minister for Health whether any external consultancy, economic review, or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme since 2020. [39198/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Departmental Schemes.
299 questions match, newest first.
1299. Deputy Ken O'Flynn asked the Minister for Health whether any structured patient follow-up programme exists for persons returning to Ireland following procedures funded under the treatment abroad scheme. [39201/26]
1301. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money framework exists comparing the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme against equivalent treatment pathways domestically. [39203/26]
1302. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any provider-level performance monitoring system in respect of overseas hospitals or clinics receiving treatment abroad scheme referrals. [39204/26]
1303. Deputy Ken O'Flynn asked the Minister for Health whether any formal patient safety governance framework exists specifically governing procedures funded under the treatment abroad scheme. [39205/26]
1306. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured clinical outcome monitoring under the treatment abroad scheme has been identified on any Departmental or HSE risk register. [39208/26]
1307. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a category-specific expenditure breakdown for procedures funded under the treatment abroad scheme; and if so, whether gender affirmation surgeries are separately identifiable within those records. [39210/26]
1308. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been conducted regarding overseas gender affirmation surgeries funded under the treatment abroad scheme since 2020. [39211/26]
1309. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment, governance review or assurance process has been undertaken specifically relating to overseas gender affirmation surgery approvals under the treatment abroad scheme. [39212/26]
1313. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the total annual number of gender affirmation surgery applications approved under the treatment abroad scheme since 2020, by year. [39216/26]
1336. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains any dataset identifying the highest-cost individual referrals funded annually; and if she will provide the ten highest annual individual treatment costs since 2020 in anonymised form. [39341/26]
1337. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost treatment abroad scheme approvals; and if so, the criteria used to classify cases as high-cost. [39345/26]
1378. Deputy Marie Sherlock asked the Minister for Health the estimated full year cost of providing reimbursement under the general medical services scheme for sublingual immunotherapy for house dust mite allergy; the number of patients estimated to be eligible for such treatment; and the specific assumptions used in calculating this estimate. [39643/26]
1409. Deputy Ken O'Flynn asked the Minister for Health whether any national policy exists setting minimum audit, outcome-monitoring or data-governance requirements before new healthcare pathways, treatment programmes or overseas referral arrangements are operationally supported by the State. [39758/26]
1416. Deputy Ken O'Flynn asked the Minister for Health whether any Departmental or HSE official holds specific national responsibility for governance oversight of minors referred abroad under the Treatment Abroad Scheme; and if she will provide details. [39775/26]
1422. Deputy Ken O'Flynn asked the Minister for Health whether any national framework exists governing audit, quality assurance and value-for-money assessment of overseas referrals funded through the Treatment Abroad Scheme. [39781/26]
385. Deputy Louis O'Hara asked the Minister for Health whether chronic asthma is a condition covered under the long-term illness scheme; if not, the rationale for not including it under the scheme; if she will consider adding asthma to the conditions supported by the long-term illness scheme; and if she will make a statement on the matter. [38692/26]
386. Deputy Louis O'Hara asked the Minister for Health whether chronic asthma is a condition covered under the long-term illness scheme; if not, to provide the rationale for not including it under the scheme; if consideration is being given to adding asthma to the conditions supported by the long-term illness scheme; and if she will make a statement on the matter. [38693/26]
249. Deputy Pádraig Rice asked the Minister for Health if she will consider expanding the long-term illness scheme to include asthma; and if she will make a statement on the matter. [35631/26]
1167. Deputy Sean Fleming asked the Minister for Health if she will include asthma in the long-term illness scheme; and if she will make a statement on the matter. [34887/26]
570. Deputy Brian Stanley asked the Minister for Health the qualifying criteria for the critical illness protocol; if there is a defined list of medical conditions that qualify under this scheme; if those who contracted long-Covid while working on the frontlines during the pandemic for the HSE are eligible for this payment; and if she will make a statement on the matter. [33904/26]
843. Deputy Thomas Gould asked the Minister for Health whether fair deal applications for persons currently in hospital can be fast-tracked. [31936/26]
1010. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical criteria, thresholds, or evidentiary standards are formally defined for determining what constitutes a “proven treatment” under the Treatment Abroad Scheme. [32563/26]
1013. Deputy Ken O'Flynn asked the Minister for Health whether any cost ceilings, budget controls, or value-for-money assessments are applied to approvals under the Treatment Abroad Scheme. [32566/26]
1028. Deputy Ken O'Flynn asked the Minister for Health what formal audit schedule, risk assessment, or expenditure-control framework applies to the Treatment Abroad Scheme; who is responsible within her Department for oversight of that framework; and whether the Scheme is subject to periodic value-for-money review. [32592/26]